中文名称 | 依克立达 |
---|---|
英文名称 | Elacridar (Synonyms: GF120918; GW0918; GG918; GW120918) |
CAS号 | 143664-11-3 |
分子式 | C34H33N3O5 |
分子量 | 563.64 |
MDL | MFCD00912604 |
外观 | Light yellow to brown powder |
储存条件 | Store in a dry and dark sealed container, short-term (weeks to months) storage at 0-4 ℃, long-term (months to years) storage at -20 ℃. |
Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. Elacridar can be used to examine the influence of efflux transporters on agent distribution to brain and the research of cancer.
GF120918 (Elacridar) is a very potent inhibitor of the ABC transporters MDR-1 (P-gp) and BCRP. GF120918 increases the bioavailability of cytotoxic anti-tumor drugs, and also leads to increased levels of anti-HIV drugs in the brain and CNS.
GF120918 (Elacridar) is an inhibitor of MDR-1 (P-gp).
buy Elacridar (GF120918) | Elacridar (GF120918) supplier | purchase Elacridar (GF120918) | Elacridar (GF120918) cost | Elacridar (GF120918) manufacturer | order Elacridar (GF120918) | Elacridar (GF120918) distributor
Elacridar | GF120918 | GW0918 | GG918 | GW120918 | ABC transporters MDR-1 (P-gp) inhibitor | N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide
© 2020-2024 凯立德生物医药技术(上海)有限公司 版权所有
沪ICP备15046197号-3
沪公网安备31011502007856号
Designed by Kuanersoft